STOCK TITAN
  1. Home
  2. Sec-filings
  3. KMDA
  4. [Form 4] KAMADA LTD Insider Trading Activity

Kamada Ltd (KMDA) director receives 30,000 stock option grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Dekel Benjamin, a director of Kamada Ltd, received a grant of 30,000 employee stock options to buy ordinary shares at an exercise price of $7.5200 per share. The options vest in four equal annual installments over four years, are exercisable for 10 years, and are held indirectly by a trustee under the company's 2011 Share Award Plan.

Positive

  • None.

Negative

  • None.
Insider Dekel Benjamin
Role Director
Type Security Shares Price Value
Grant/Award Employee Stock Option (right to buy) F1, F2, F3 30,000 $0.00 $0.00
Holdings After Transaction: Employee Stock Option (right to buy) — 30,000 shares (Indirect, Held by trustee)
Footnotes (3)
  1. F1. The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.
  2. F2. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.
  3. F3. Held by trustee under the Company's 2011 Share Award Plan.
Options granted 30000.0000 options Employee stock options granted to director Dekel Benjamin on 2026-08-05
Exercise price $7.5200 per share Exercise price for the employee stock options, presented in U.S. dollars
Vesting period 4 years Options vest in four equal annual installments over four years
Annual vesting rate 25% Portion of the options that vests on each anniversary of the grant date
Option term 10 years Period during which the options are exercisable following the grant date
Employee Stock Option (right to buy) financial
"Security title reported as Employee Stock Option (right to buy)"
exercise price financial
"The exercise price presented in U.S. dollars represent a convenience conversion"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Held by trustee under the Company's 2011 Share Award Plan. financial
"Held by trustee under the Company's 2011 Share Award Plan."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did Kamada Ltd (KMDA) report for Dekel Benjamin?
Kamada Ltd reported that director Dekel Benjamin received a grant of 30,000 employee stock options to buy ordinary shares at an exercise price of $7.5200 per share, held indirectly by a trustee under the company’s 2011 Share Award Plan.

What are the key terms of the 30,000 stock options granted at Kamada Ltd (KMDA)?
The grant covers 30,000 employee stock options with an exercise price of $7.5200 per share. The options are exercisable for 10 years from the grant date and relate to Kamada Ltd ordinary shares held via a trustee.

How do the Kamada Ltd (KMDA) options granted to Dekel Benjamin vest?
The options vest over four years in four equal installments. Specifically, 25% of the options vest on each anniversary of the grant date, until all 30,000 options have vested, provided the applicable vesting conditions continue to be met.

Are the Kamada Ltd (KMDA) options held directly by Dekel Benjamin?
No. The Form 4 states the options are held indirectly, "held by trustee" under the company’s 2011 Share Award Plan. This means a trustee entity holds the options for his benefit rather than direct personal registration.

Was the Kamada Ltd (KMDA) option grant made under a Rule 10b5-1 trading plan?
The Rule 10b5-1 checkbox is not affirmed for this filing, and there is no footnote indicating a trading plan. The transaction is characterized as a grant or award acquisition of derivative securities, rather than a trade executed under a pre-arranged plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dekel Benjamin
(Last)(First)(Middle)
2 HOLTZMAN ST.
(Street)
REHOVOT
(City)(State)(Zip)
ISRAEL
(Country)		2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$7.52(1)08/05/2026A30,000 (2) (2)Ordinary Shares30,000$0.0030,000IHeld by trustee(3)
Explanation of Responses:
1. The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.
2. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.
3. Held by trustee under the Company's 2011 Share Award Plan.
/s/ Benjamin Dekel08/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR